117 related articles for article (PubMed ID: 10637003)
1. Long-term effectiveness of photodynamic therapy by using a hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats.
Kanai M; Obana A; Gohto Y; Nagata S; Miki T; Kaneda K; Nakajima S
Lasers Surg Med; 2000; 26(1):48-57. PubMed ID: 10637003
[TBL] [Abstract][Full Text] [Related]
2. Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys.
Obana A; Gohto Y; Kanai M; Nakajima S; Kaneda K; Miki T
Arch Ophthalmol; 2000 May; 118(5):650-8. PubMed ID: 10815157
[TBL] [Abstract][Full Text] [Related]
3. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.
Obana A; Gohto Y; Kaneda K; Nakajima S; Miki T
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2639-45. PubMed ID: 11581211
[TBL] [Abstract][Full Text] [Related]
4. Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.
Obana A; Gohto Y; Kaneda K; Nakajima S; Takemura T; Miki T
Lasers Surg Med; 1999; 24(3):209-22. PubMed ID: 10229152
[TBL] [Abstract][Full Text] [Related]
5. [Effect of photodynamic therapy with ATX-S 10 (Na) on experimental choroidal neovascularization].
Hirose T; Nakajima M; Kyou T; Yuzawa M
Nippon Ganka Gakkai Zasshi; 2006 Jun; 110(6):445-53. PubMed ID: 16808159
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
Berdugo M; Bejjani RA; Valamanesh F; Savoldelli M; Jeanny JC; Blanc D; Ficheux H; Scherz A; Salomon Y; BenEzra D; Behar-Cohen F
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
[TBL] [Abstract][Full Text] [Related]
7. Scanning laser system for photodynamic therapy of choroidal neovascularization.
Obana A; Gohto Y
Lasers Surg Med; 2002; 30(5):370-5. PubMed ID: 12116330
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the phototoxicity of two chrolin type photosensitizers, ATX-S10(Na) and verteporfin, on vascular endothelial and retinal pigment epithelial cells.
Huang Y; Obana A; Gohto Y; Nakajima S
Lasers Surg Med; 2004; 34(3):216-26. PubMed ID: 15022248
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
Mori K; Yoneya S; Anzail K; Kabasawa S; Sodeyama T; Peyman GA; Moshfeghi DM
Retina; 2001; 21(5):499-508. PubMed ID: 11642380
[TBL] [Abstract][Full Text] [Related]
10. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser.
Mori M; Sakata I; Hirano T; Obana A; Nakajima S; Hikida M; Kumagai T
Jpn J Cancer Res; 2000 Jul; 91(7):753-9. PubMed ID: 10920284
[TBL] [Abstract][Full Text] [Related]
12. Treatment parameters for selective occlusion of experimental corneal neovascularization by photodynamic therapy using a water soluble photosensitizer, ATX-S10(Na).
Gohto Y; Obana A; Kanai M; Nagata S; Nakajima S; Miki T
Exp Eye Res; 2001 Jan; 72(1):13-22. PubMed ID: 11133178
[TBL] [Abstract][Full Text] [Related]
13. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES
Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
[TBL] [Abstract][Full Text] [Related]
14. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
Schlötzer-Schrehardt U; Viestenz A; Naumann GO; Laqua H; Michels S; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):748-57. PubMed ID: 12271373
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of experimental choroidal neovascularization in the mouse.
Odergren A; Ming Y; Kvanta A
Curr Eye Res; 2006 Sep; 31(9):765-74. PubMed ID: 16966149
[TBL] [Abstract][Full Text] [Related]
16. Dynamic observation of selective accumulation of a photosensitizer and its photodynamic effects in rat experimental choroidal neovascularization.
Hikichi T; Mori F; Nakajima S; Takamiya TA; Takeda M; Sasaki M; Horikawa Y; Yoshida A
Retina; 2001; 21(2):126-31. PubMed ID: 11321138
[TBL] [Abstract][Full Text] [Related]
17. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of photosensitizer ATX-S10 (Na) in experimental corneal neovascularization.
Gohto Y; Obana A; Kaneda K; Nakajima S; Takemura T; Miki T
Jpn J Ophthalmol; 2000; 44(4):348-53. PubMed ID: 10974289
[TBL] [Abstract][Full Text] [Related]
19. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
Zacks DN; Ezra E; Terada Y; Michaud N; Connolly E; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples.
Schmidt-Erfurth U; Miller J; Sickenberg M; Bunse A; Laqua H; Gragoudas E; Zografos L; Birngruber R; van den Bergh H; Strong A; Manjuris U; Fsadni M; Lane AM; Piguet B; Bressler NM
Graefes Arch Clin Exp Ophthalmol; 1998 May; 236(5):365-74. PubMed ID: 9602321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
